Journal article
Prevention and management of co-morbidities in SLE
La Presse médicale (1983), v 43(6), pp E187-E195
01 Jun 2014
PMID: 24855047
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
The prognosis and survival of patients with systemic lupus erythematosus (SLE) have improved over the past few decades. The major cause of death is no longer active lupus, but instead cardiovascular disease, complications of renal failure, and malignancy. Co-morbid factors, including both traditional and non-traditional cardiovascular risk factors, can be targeted according to accepted guidelines. We will emphasize the deleterious effect of corticosteroids in contributing to cardiovascular risk and the need to shift maintenance prednisone doses to a much lower threshold.
Metrics
1 Record Views
Details
- Title
- Prevention and management of co-morbidities in SLE
- Creators
- Tanmayee Bichile - Johns Hopkins UniversityMichelle Petri - Johns Hopkins University
- Publication Details
- La Presse médicale (1983), v 43(6), pp E187-E195
- Publisher
- Elsevier
- Number of pages
- 9
- Grant note
- AR 43727 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- General Internal Medicine
- Web of Science ID
- WOS:000440386300007
- Scopus ID
- 2-s2.0-84902553318
- Other Identifier
- 991022193497204721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
Source: SDGs in the Output
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Rheumatology